IRF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.317000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.799250E-01
Normal-vs-Stage2
3.483000E-01
Normal-vs-Stage3
1.074820E-01
Normal-vs-Stage4
4.597600E-01
Stage1-vs-Stage2
9.139200E-01
Stage1-vs-Stage3
2.071200E-01
Stage1-vs-Stage4
7.563400E-01
Stage2-vs-Stage3
1.564430E-01
Stage2-vs-Stage4
5.528000E-01
Stage3-vs-Stage4
3.230400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.246200E-01
Normal-vs-AfricanAmerican
2.067400E-01
Normal-vs-Asian
1.334010E-01
Caucasian-vs-AfricanAmerican
6.396000E-01
Caucasian-vs-Asian
8.015200E-01
AfricanAmerican-vs-Asian
8.429000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.212400E-01
Normal-vs-Female
3.435200E-01
Male-vs-Female
5.541200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.152600E-01
Normal-vs-Age(41-60Yrs)
4.095800E-01
Normal-vs-Age(61-80Yrs)
1.100230E-02
Normal-vs-Age(81-100Yrs)
3.154800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.434200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.916800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.306200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.592280E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.120000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.775200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.850400E-01
Normal-vs-Daily Drinker
4.432100E-02
Normal-vs-Weekly Drinker
4.833900E-02
Normal-vs-Occasional Drinker
8.665900E-02
Normal-vs-Social Drinker
3.923400E-01
Non Drinker-vs-Daily Drinker
8.468000E-01
Non Drinker-vs-Weekly Drinker
7.880800E-01
Non Drinker-vs-Occasional Drinker
2.320000E-01
Non Drinker-vs-Social Drinker
1.238020E-01
Daily Drinker-vs-Weekly Drinker
7.189000E-01
Daily Drinker-vs-Occasional Drinker
4.090000E-01
Daily Drinker-vs-Social Drinker
2.812000E-01
Weekly Drinker-vs-Occasional Drinker
2.729600E-01
Weekly Drinker-vs-Social Drinker
1.618950E-01
Occasional Drinker-vs-Social Drinker
8.221000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.070200E-01
Normal-vs-Grade 2
3.367900E-02
Normal-vs-Grade 3
5.826000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.944200E-02
Grade 1-vs-Grade 3
1.081840E-01
Grade 1-vs-Grade 4
2.070200E-01
Grade 2-vs-Grade 3
7.031800E-01
Grade 2-vs-Grade 4
3.367900E-02
Grade 3-vs-Grade 4
5.826000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.183800E-02
Normal-vs-NonDiabetic
3.175800E-01
Diabetic-vs-NonDiabetic
6.891400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.031400E-01
Normal-vs-NoPancreatitis
3.102000E-01
Pancreatitis-vs-NoPancreatitis
3.690400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.091400E-01
Normal-vs-N1
3.495400E-01
N0-vs-N1
3.041400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.649000E-01
Normal-vs-TP53-NonMutant
3.860600E-01
TP53-Mutant-vs-TP53-NonMutant
2.430200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
